Comparative study of Mycobacterium tuberculosis and Mycobacterium bovis protein profiles
Abstract
Aim: Despite the drug resistance Mycobacterium bovis and Mycobacterium tuberculosis (MTB) are still regarded as two of the global health problems in the world. In the present study, a comparison was made between protein profiles of Mycobacterium bovis and MTB in order to achieve effective biomarkers for diagnosis of tuberculosis.
Methods: The clinical samples, sputum and gastric lavage (and the other samples) were processed by N-acetyl-L-cysteine-sodium hydroxide methods and consequently were cultured on Lowenstein–Jensen medium. Mycobacterium tuberculosis and bovis strains were distinguished according to the biochemical tests and susceptibility testing system. Colonies were grown in 7H9 medium and membrane and secretory proteins were extracted, purified by ammonium sulfate and refrigerated alcohol methods.
Results: The protein contents were measured by Bradford method. Comparison of protein bands in each strain were performed by one dimensional electrophoresis.
The major discrepancy between the two strains in the banding separation membrane proteins could be observed in 45 and 60 KDa and also less than 45 and 14 KDa.
Conclusion: The results showed that discrepancy in the proteins bands could be used as protein effective biomarker for tuberculosis diagnosis. We should use antibody against tuberculosis for further investigation for rapid tuberculosis diagnosis.
Keywords
Kaynakça
- 1. Global tuberculosis Report. 2015. World health organization, 2015
- 2. World Health Organization. Global tuberculosis control; surveillance planning, financing. WHO Report. Geneva, Switzerland: WHO; 2014.
- 3. Majoor CJ, Magis-Escurra C, Van Ingen J, Boeree MJ, Van Soolingen D. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993–2007. Emerg Infect Dis. 2011;17:457-63.
- 4. Somoskovi A, Dormandy J, Parsons LM, Kaswa M, SengGoh K, Rastogi N, et al. Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: identification of a speciesspecific pncA mutation in “Mycobacterium canettii” and the reliable and rapid predictor of pyrazinamide resistance. JCM. 2007;45:595-99.
- 5. Barouni AS, Augusto CJ, Lopes MT, Zanini MS, Salas CE. A pnca polymorphism to differentiate between Mycobacterium bovis and Mycobacterium tuberculosis. Mol Cell Probes. 2004;18:167–70.
- 6. Monteros LE, Galan JC, Gutierrez M, Samper S, Garcia Marin JF, Martin C, et al. Allele- specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovispnca sequence polymorphism. J Clin Microbiol. 1998;36:239–42.
- 7. Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC. Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 2009;21:331-38.
- 8. Sonnenberg MG, Belisle JT. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun 1997; 65:4515-24.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Araştırma Makalesi
Yazarlar
Mohammad Kazem Sharifi Yazdi
*
Bu kişi benim
Iran
Amir Houshang Beheshtnejad
Bu kişi benim
Iran
Azim Hedayatpour
Bu kişi benim
Iran
Sara Sharifi-yazdi
Bu kişi benim
Iran
Fariborz Mehrani
Bu kişi benim
Yayımlanma Tarihi
1 Eylül 2018
Gönderilme Tarihi
21 Nisan 2018
Kabul Tarihi
10 Mayıs 2018
Yayımlandığı Sayı
Yıl 2018 Cilt: 2 Sayı: 3